Kontafarma China Holdings Ltd
Kontafarma China Holdings Ltd (1312.HK) Stock Forecast & Price Predictions
Get the latest Kontafarma China Holdings Ltd (1312.HK) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.
Model Information
The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerMonthly Forecast
Quarterly Forecast
Yearly Forecast
3 Years Forecast
5 Years Forecast
7 Years Forecast
Kontafarma China Holdings Ltd Stock Forecast Summary
Kontafarma China Holdings Ltd (1312.HK) stock is currently priced at $0.03. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $0.03.
In the long term, 1312.HK shows a bearish trend. The 2027 forecast points to $0.02 (-25.39% change), while the 2031 forecast suggests $0.01 (-76.06% change). Looking 7 years ahead, projections estimate the stock could trade near $0.00, a -99.71% change from today’s price.
Bearish
Bearish
Bearish
This mix indicates that Kontafarma China Holdings Ltd stock is expected to face downside risk over the coming years.
Investment Calculator
Estimate your potential returns on 1312.HK based on our AI price forecasts. Enter your investment amount and select a target date.
Based on your investment of HK$1,000.00 in Kontafarma China Holdings Ltd and holding until April 4th, 2027, you could make a potential HK$253.94 loss, reflecting a -25.4% ROI over the next 365 days.
$Shares Bought
33,333.3333
@ HK$0.03/share
~Forecast Price
HK$0.02
1-year AI forecast
$Est. Portfolio Value
HK$746.06
HK$253.94 loss
%ROI
-25.4%
return on investment
Kontafarma China Holdings Ltd yearly Price Forecast Chart
Explore the yearly forecast chart for 1312.HK, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Kontafarma China Holdings Ltd over different timeframes.
No forecast data available
No prediction data found for this time period.
Forecasting data is not available for 1312.HKForecasting details for 1312.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.Kontafarma China Holdings Ltd Stock Forecast 2026
The forecast for Kontafarma China Holdings Ltd (1312.HK) in 2026 suggests a price of $0.02, representing a -25.39% move from today’s price.
Average Target: $0.02
Market Outlook: bearish based on current trend indicators.
Key Drivers in 2026:- Earnings growth projections.
- Competitive performance in the Basic Materials.
- Macroeconomic factors such as interest rates and inflation.
Kontafarma China Holdings Ltd Stock Forecast 2030
By 2030, Meyka AI projects 1312.HK could trade near $0.01, showing a potential -76.06% compared to current levels.
Average Target: $0.01
Market Outlook: bearish.
What could influence the 2030 forecast:- Technological innovation and product cycles.
- Expansion into global markets.
- Long-term investor sentiment toward Kontafarma China Holdings Ltd.
Kontafarma China Holdings Ltd 7-Year Stock Forecast (2032–2033)
Looking 7 years ahead, the long-term forecast for 1312.HK points to a price around $0.00, which is a projected -99.71% move from today’s level.
Average Target: $0.00
Outlook: bearish, depending on macroeconomic conditions and sector growth.
Long-Term Drivers:- Global economic expansion or contraction.
- Regulatory and policy environment.
- Kontafarma China Holdings Ltd’s ability to maintain market leadership.